MeiraGTx Holdings (MGTX) Shares Outstanding (Diluted Average) (2020 - 2025)

MeiraGTx Holdings (MGTX) reported Shares Outstanding (Diluted Average) of $80.4 million for Q4 2025, up 15.19% on a YoY basis from $69.8 million in Q4 2024, and down 0.64% quarter-over-quarter from $80.9 million in Q3 2025.

MeiraGTx Holdings (MGTX) Shares Outstanding (Diluted Average) (2020 - 2025) Analysis & Trends

MeiraGTx Holdings has reported Shares Outstanding (Diluted Average) for 6 years, with the latest figure at $80.4 million in Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) rose 15.19% year-over-year to $80.4 million; the trailing twelve-month figure through Dec 2025 stood at $80.4 million (up 15.19% YoY), and the FY2025 full-year result was $80.4 million, up 15.19% from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 stood at $80.4 million, down from $80.9 million in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $80.9 million in Q3 2025, with the low at $44.0 million in Q1 2021.
  • Historically, Shares Outstanding (Diluted Average) has averaged $58.1 million across 5 years, with a median of $54.2 million in 2023.
  • Annual changes were most pronounced in 2022 — Shares Outstanding (Diluted Average) advanced 1.02% — and 2023, when it jumped 33.41%.
  • MeiraGTx Holdings' Shares Outstanding (Diluted Average) stood at $44.1 million in 2021, then rose by 2.35% to $45.2 million in 2022, then increased by 25.03% to $56.5 million in 2023, then climbed by 23.61% to $69.8 million in 2024, then gained by 15.19% to $80.4 million in 2025.
  • The last three Shares Outstanding (Diluted Average) figures came in at $80.4 million (Q4 2025), $80.9 million (Q3 2025), and $80.6 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 810.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 1.48 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 256.30 Mn
9 Abivax 91.96 Bn 91.96 Bn - 92.44 Mn
10 MeiraGTx Holdings 910.47 Mn 844.54 Mn 74.89 Mn 80.43 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 80.43 Mn
Sep 30, 2025 80.95 Mn
Jun 30, 2025 80.59 Mn
Mar 31, 2025 79.03 Mn
Dec 31, 2024 69.82 Mn
Sep 30, 2024 71.63 Mn
Jun 30, 2024 64.38 Mn
Mar 31, 2024 64.07 Mn
Dec 31, 2023 56.49 Mn
Sep 30, 2023 59.53 Mn
Jun 30, 2023 52.01 Mn
Mar 31, 2023 48.64 Mn
Dec 31, 2022 45.18 Mn
Sep 30, 2022 44.62 Mn
Jun 30, 2022 44.67 Mn
Mar 31, 2022 44.50 Mn
Dec 31, 2021 44.14 Mn
Sep 30, 2021 44.17 Mn
Jun 30, 2021 44.14 Mn
Mar 31, 2021 43.97 Mn